The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us


5137 Westlawn
Iowa City IA 52242
(319) 335-6660; fax (319) 335-8034

Release: Feb. 2, 2001

(NOTE TO EDITORS: This call for participants was originally released on Aug. 18, 2000. The study is ongoing.)

People with gambling problems invited to participate in UI study

IOWA CITY, Iowa -- People who are problem gamblers -- whose gambling is out of control and leading to personal distress and/or marital, legal and financial difficulties -- are invited to participate in a University of Iowa Health Care treatment study. The study will examine the effectiveness of bupropion in treating pathological gambling. Bupropion, also known as Wellbutrin or Zyban, already is approved by the Food and Drug Administration for treating depression and smoking addiction.

Participants must be age 18 or older and cannot be depressed or abusing alcohol or drugs. In addition, participants cannot have any eating disorder or a history of seizures. Women must not be pregnant or planning to get pregnant during the study period. All participants will receive the study medication. Study participation involves a total of five visits at the UI over two months. The first visit includes a physical examination. The four follow-up visits involve assessment of the participant's gambling and other problems as well as a discussion of the medication and its side effects.

For more information, contact the study's lead investigator, Donald W. Black, M.D., UI professor of psychiatry at (319) 353-4431.

University of Iowa Health Care describes the partnership between the UI College of Medicine and the UI Hospitals and Clinics and the patient care, medical education and research programs and services they provide.